1. Diagnostic performance of a point-of-care molecular system for the detection of SARS-CoV-2 in Peru.
- Author
-
Puyén ZM, Araujo-Castillo R, Giraldo J, Gutierrez K, and Rojas-Serrano N
- Subjects
- Humans, Peru, COVID-19 Nucleic Acid Testing methods, Pharynx virology, Point-of-Care Systems, Real-Time Polymerase Chain Reaction, Point-of-Care Testing, COVID-19 diagnosis, SARS-CoV-2 isolation & purification, Sensitivity and Specificity
- Abstract
The present study assessed the diagnostic performance of the Xpert®Xpress SARS-CoV-2 test in comparison with the Charité protocol real-time RT PCR for the detection of SARS-CoV-2 in Peruvian patients. This was a diagnostic test study that included 100 nasal and pharyngeal swab samples. We obtained an overall concordance of 98.70% (95%CI: 92.98-99.97), with a kappa coefficient of 0.97 (95%CI: 0.86-1.00) and sensitivity and relative specificity rates of 100% and 96.15%, respectively. Additionally, the percentage of the area under the ROC curve was 98.08% in both cases, and an analytical specificity rate of 100% was obtained for the different respiratory viruses evaluated. In conclusion, the Xpert®Xpress SARS-CoV-2 test, by using nasal and pharyngeal swab samples, was highly sensitive and specific, and the kappa coefficient showed an excellent correlation when compared to the reference test. Motivation for the study. To describe and evaluate a closed molecular platform, easy to use and of importance in Peru for the management of diseases of public health priority, now implemented for the detection of SARS-CoV-2. Main findings. Highly sensitive and specific molecular test, with excellent correlation compared to the reference test for detecting SARS-CoV-2. Implications. Can be used in point-of-care laboratories for rapid molecular detection of different infectious agents, including SARS-CoV-2. Little expertise and minimal infrastructure are required to implement it.
- Published
- 2024
- Full Text
- View/download PDF